Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Asensus Surgical, Inc. (ASXC)

0.83   -0.012 (-1.39%) 01-27 16:00
Open: 0.84 Pre. Close: 0.8417
High: 0.874 Low: 0.7801
Volume: 2,247,442 Market Cap: 197(M)

Technical analysis

as of: 2023-01-27 4:42:38 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.02     One year: 1.19
Support: Support1: 0.5    Support2: 0.28
Resistance: Resistance1: 0.87    Resistance2: 1.02
Pivot: 0.62
Moving Average: MA(5): 0.74     MA(20): 0.55
MA(100): 0.45     MA(250): 0.5
MACD: MACD(12,26): 0.1     Signal(9): 0
Stochastic oscillator: %K(14,3): 92.1     %D(3): 90.7
RSI: RSI(14): 79.8
52-week: High: 0.92  Low: 0.28
Average Vol(K): 3-Month: 1,129 (K)  10-Days: 2,500 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ASXC ] has closed below upper band by 8.9%. Bollinger Bands are 238.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 14 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.88 - 0.88 0.88 - 0.88
Low: 0.77 - 0.78 0.78 - 0.78
Close: 0.82 - 0.83 0.83 - 0.84

Company Description

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Headline News

Fri, 27 Jan 2023
Is Asensus Surgical Inc (ASXC) a Stock to Watch After Gaining 23.88% This Week? - InvestorsObserver

Fri, 27 Jan 2023
Market cap of Asensus Surgical Inc. [ASXC] reaches 200.64M – now ... - DBTNews

Fri, 27 Jan 2023
Asensus Surgical Inc. (AMEX:ASXC) Is Up 169.69% Over The Past ... - Marketing Sentinel

Thu, 26 Jan 2023
7 Top Penny Stocks Under $1 To Watch Before Next Week - Penny Stocks

Mon, 23 Jan 2023
Asensus Surgical wins CE mark for surgical robot's machine vision - Mass Device

Thu, 19 Jan 2023
Should You Add Asensus Surgical Inc (ASXC) Stock to Your ... - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 237 (M)
% Held by Insiders 2.3309e+008 (%)
% Held by Institutions 1 (%)
Shares Short 8,670 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -6.331e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 78.3
Return on Equity (ttm) -29.2
Qtrly Rev. Growth 7.1e+006
Gross Profit (p.s.) -0.01
Sales Per Share 0.02
EBITDA (p.s.) -0.2
Qtrly Earnings Growth -0.3
Operating Cash Flow 0 (M)
Levered Free Cash Flow -58 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 28.35
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 8.82e+006
Dividend Yield 0%
Dividend Pay Date 2019-12-11
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.